Home Blood Pressure Outcomes Evaluation Study (HOMESTEAD)
家庭血压结果评估研究 (HOMESTEAD)
基本信息
- 批准号:10619516
- 负责人:
- 金额:$ 47.19万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-06-01 至 2026-05-31
- 项目状态:未结题
- 来源:
- 关键词:Acute Renal Failure with Renal Papillary NecrosisAddressAdherenceAdultAdverse eventAgeAmericanAmerican Heart AssociationAntihypertensive AgentsBlood PressureCardiologyCardiovascular systemCaringCase ManagementCase ManagerCessation of lifeCharacteristicsChronic DiseaseClinicClinicalClinical TrialsCountryDataDiagnosisDisease ManagementEffectivenessElectrolytesEnrollmentEthnic OriginEvaluation StudiesEventGoalsGuidelinesHomeHome Blood Pressure MonitoringHypertensionIndividualKnowledgeLinkMeasurementMeasuresMethodsMorbidity - disease rateNephrologyObservational StudyOutcomePatient SelectionPatientsPersonsPharmaceutical PreparationsPopulation HeterogeneityProviderRaceRandomized, Controlled TrialsRecommendationReportingRiskRisk FactorsRisk ReductionSiteSocioeconomic StatusSubgroupTimeUnited States Preventative Services Task ForceVariantVeteransadverse event riskadverse outcomeblood pressure medicationblood pressure reductionclinical practiceclinical riskcohortcollegecomorbiditydesigneffectiveness evaluationhealth datahypertension controlimplementation strategyimprovedmedication compliancemortalityparticipant enrollmentprogramsroutine practicesextelehealthtransmission process
项目摘要
PROJECT ABSTRACT
Over 100 million US adults have hypertension, the number one chronic disease risk factor in the world. The
United States Preventive Services Task Force and the 2017 American College of Cardiology/American Heart
Association blood pressure (BP) guidelines recommends measuring BP outside of the clinic for the diagnosis
and management of hypertension. Home blood pressure monitoring (HBPM) involves self-measurement of BP
by the patient and is the most common method for assessing out-of-office BP in the US. The guideline
recommendations are based on high-quality observational studies in which out-of-office BP was typically
obtained at a single point and individuals with high out-of-office BP were observed to have higher rates of
cardiovascular outcomes and increased rates of all-cause mortality, regardless of office BP levels. Additionally,
clinical trials have demonstrated that HBPM reduces clinic BP over short 6-12 month time frames, especially
when combined with disease management programs. There are no studies evaluating the effectiveness of
HBPM in routine clinical practice in a diverse population from across the country. Additionally, there are a lack
of data on: a) whether use of HBPM reduces risk for clinical outcomes; b) the impact of HBPM on both short-
and long-term clinic BP, clinical inertia, and medication adherence in routine clinical practice; and c) how
clinicians and patients utilize HBPM. Over the last ~10 years, approximately 400,000 Veterans have measured
home BPs as part of the VA’s telehealth program. We propose to identify Veterans age 18-90 years with
uncontrolled clinic BP enrolled in HBPM programs and a cohort of Veterans not enrolled in HBPM programs.
We will link telehealth data to clinical and outcome data. The proposal will make use of the large number of
patients enrolled in the VA’s HBPM program and the variation in how the HBPM program is implemented
across VA sites. In Aim 1, we will evaluate the effect of HBPM on major adverse cardiovascular events, non-
cancer mortality, and adverse events. In Aim 2, we will assess the impact of HBPM on clinic BP, BP
medication intensification, and medication adherence. In Aim 3, we will determine facility-, provider-, and
patient-level factors associated with use of HBPM in routine practice. Results will establish a) the long-term
benefits of HBPM, b) the association between HBPM and clinical events, and c) the effects in important
subgroups. These findings will inform selection of patients for and the design of a much-needed randomized
controlled trial evaluating the effect of HBPM on clinical outcomes compared to office-based hypertension
management. Additionally, identifying factors associated with greater reductions in BP and greater number of
home BP values transmitted, such as case management programs, may identify barriers to adherence that can
be addressed and inform implementation strategies and the use of HBPM in clinical practice. The proposed
study will answer questions critically important to implementation of HBPM in routine clinical practice with the
ultimate goal of reducing the morbidity and mortality associated with hypertension.
项目摘要
超过 1 亿美国成年人患有高血压,这是世界上排名第一的慢性病危险因素。这
美国预防服务工作组和 2017 年美国心脏病学会/American Heart
协会血压 (BP) 指南建议在诊所外测量血压以进行诊断
和高血压的管理。家庭血压监测(HBPM)涉及自我测量血压
由患者自行测量,是美国评估诊室外血压的最常用方法。指导方针
建议基于高质量的观察性研究,其中诊室外血压通常是
在单点获得的结果,观察到诊室外血压高的个体的发生率更高
心血管结局和全因死亡率增加,无论诊室血压水平如何。此外,
临床试验表明,HBPM 在短短 6-12 个月的时间内降低了诊所血压,尤其是
与疾病管理计划相结合。尚无研究评估其有效性
HBPM 在全国各地不同人群的常规临床实践中。此外,还缺乏
有关以下方面的数据:a) 使用 HBPM 是否会降低临床结果的风险; b) HBPM 对短期的影响
以及常规临床实践中的长期临床血压、临床惯性和用药依从性; c) 如何
临床医生和患者使用 HBPM。在过去约 10 年中,大约 400,000 名退伍军人测量了
作为 VA 远程医疗计划的一部分的家庭 BP。我们建议确定 18-90 岁的退伍军人
参加 HBPM 计划的不受控制的诊所 BP 和一群未参加 HBPM 计划的退伍军人。
我们将把远程医疗数据与临床和结果数据联系起来。该提案将利用大量
参加 VA HBPM 计划的患者以及 HBPM 计划实施方式的变化
跨 VA 站点。在目标 1 中,我们将评估 HBPM 对主要不良心血管事件(非
癌症死亡率和不良事件。在目标 2 中,我们将评估 HBPM 对诊所血压、血压的影响
药物强化和药物依从性。在目标 3 中,我们将确定设施、提供商和
与日常实践中使用 HBPM 相关的患者层面因素。结果将建立 a) 长期
HBPM 的益处,b) HBPM 与临床事件之间的关联,以及 c) 对重要疾病的影响
亚组。这些发现将为患者的选择和急需的随机试验的设计提供信息
对照试验评估 HBPM 与办公室高血压相比对临床结果的影响
管理。此外,确定与血压大幅降低和更多数量相关的因素
传输的家庭血压值(例如病例管理计划)可能会识别依从性的障碍
予以解决并为实施策略和 HBPM 在临床实践中的使用提供信息。拟议的
研究将回答对于在常规临床实践中实施 HBPM 至关重要的问题
最终目标是降低高血压相关的发病率和死亡率。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Paul Englund Drawz其他文献
Paul Englund Drawz的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Paul Englund Drawz', 18)}}的其他基金
Home Blood Pressure Outcomes Evaluation Study (HOMESTEAD)
家庭血压结果评估研究 (HOMESTEAD)
- 批准号:
10364199 - 财政年份:2022
- 资助金额:
$ 47.19万 - 项目类别:
Blood Pressure and Kidney Function - SPRINT vs Electronic Health Record Data
血压和肾功能 - SPRINT 与电子健康记录数据
- 批准号:
10229386 - 财政年份:2017
- 资助金额:
$ 47.19万 - 项目类别:
Blood Pressure and Kidney Function - SPRINT vs Electronic Health Record Data
血压和肾功能 - SPRINT 与电子健康记录数据
- 批准号:
9398771 - 财政年份:2017
- 资助金额:
$ 47.19万 - 项目类别:
Effect of Standard vs Intense Hypertension Management on Nighttime Blood Pressure
标准与强化高血压管理对夜间血压的影响
- 批准号:
8768575 - 财政年份:2014
- 资助金额:
$ 47.19万 - 项目类别:
Effect of Standard vs Intense Hypertension Management on Nighttime Blood Pressure
标准与强化高血压管理对夜间血压的影响
- 批准号:
8898067 - 财政年份:2014
- 资助金额:
$ 47.19万 - 项目类别:
Epidemiology and pathophysiology of elevated nighttime blood pressure in CKD
CKD 夜间血压升高的流行病学和病理生理学
- 批准号:
8065537 - 财政年份:2010
- 资助金额:
$ 47.19万 - 项目类别:
Epidemiology and pathophysiology of elevated nighttime blood pressure in CKD
CKD 夜间血压升高的流行病学和病理生理学
- 批准号:
8514589 - 财政年份:2010
- 资助金额:
$ 47.19万 - 项目类别:
Epidemiology and pathophysiology of elevated nighttime blood pressure in CKD
CKD 夜间血压升高的流行病学和病理生理学
- 批准号:
8299093 - 财政年份:2010
- 资助金额:
$ 47.19万 - 项目类别:
Epidemiology and pathophysiology of elevated nighttime blood pressure in CKD
CKD 夜间血压升高的流行病学和病理生理学
- 批准号:
7875585 - 财政年份:2010
- 资助金额:
$ 47.19万 - 项目类别:
Epidemiology and pathophysiology of elevated nighttime blood pressure in CKD
CKD 夜间血压升高的流行病学和病理生理学
- 批准号:
8686829 - 财政年份:2010
- 资助金额:
$ 47.19万 - 项目类别:
相似海外基金
Pharmacy-led Transitions of Care Intervention to Address System-Level Barriers and Improve Medication Adherence in Socioeconomically Disadvantaged Populations
药房主导的护理干预转型,以解决系统层面的障碍并提高社会经济弱势群体的药物依从性
- 批准号:
10594350 - 财政年份:2023
- 资助金额:
$ 47.19万 - 项目类别:
Evaluating Centralizing Interventions to Address Low Adherence to Lung Cancer Screening Follow-up in Decentralized Settings
评估集中干预措施,以解决分散环境中肺癌筛查随访依从性低的问题
- 批准号:
10738120 - 财政年份:2023
- 资助金额:
$ 47.19万 - 项目类别:
Suubi-Mhealth: A mobile health intervention to address depression and improve ART adherence among Youth living with HIV (YLHIV) in Uganda
Suubi-Mhealth:一种移动健康干预措施,旨在解决乌干达艾滋病毒感染者 (YLHIV) 青少年的抑郁症问题并提高抗逆转录病毒疗法的依从性
- 批准号:
10526768 - 财政年份:2022
- 资助金额:
$ 47.19万 - 项目类别:
Suubi-Mhealth: A mobile health intervention to address depression and improve ART adherence among Youth living with HIV (YLHIV) in Uganda
Suubi-Mhealth:一种移动健康干预措施,旨在解决乌干达艾滋病毒感染者 (YLHIV) 青少年的抑郁症问题并提高抗逆转录病毒疗法的依从性
- 批准号:
10701072 - 财政年份:2022
- 资助金额:
$ 47.19万 - 项目类别:
A behavioral intervention for Black men who have sex with men and live with HIV to address intersectional stigma and improve antiretroviral therapy adherence
针对男男性行为且感染艾滋病毒的黑人男性进行行为干预,以解决交叉耻辱并提高抗逆转录病毒治疗的依从性
- 批准号:
10679092 - 财政年份:2021
- 资助金额:
$ 47.19万 - 项目类别:
A behavioral intervention for Black men who have sex with men and live with HIV to address intersectional stigma and improve antiretroviral therapy adherence
针对男男性行为且感染艾滋病毒的黑人男性进行行为干预,以解决交叉耻辱并提高抗逆转录病毒治疗的依从性
- 批准号:
10432133 - 财政年份:2021
- 资助金额:
$ 47.19万 - 项目类别:
A behavioral intervention for Black men who have sex with men and live with HIV to address intersectional stigma and improve antiretroviral therapy adherence
针对男男性行为且感染艾滋病毒的黑人男性进行行为干预,以解决交叉耻辱并提高抗逆转录病毒治疗的依从性
- 批准号:
10327065 - 财政年份:2021
- 资助金额:
$ 47.19万 - 项目类别:
Leveraging Technology to Address Access and Adherence to Conventional Hospital-Based Pulmonary Rehabilitation in Veterans with COPD
利用技术解决慢性阻塞性肺病退伍军人接受和坚持传统医院肺康复的问题
- 批准号:
10377366 - 财政年份:2019
- 资助金额:
$ 47.19万 - 项目类别:
Leveraging Technology to Address Access and Adherence to Conventional Hospital-Based Pulmonary Rehabilitation in Veterans with COPD
利用技术解决慢性阻塞性肺病退伍军人接受和坚持传统医院肺康复的问题
- 批准号:
10574496 - 财政年份:2019
- 资助金额:
$ 47.19万 - 项目类别:
Targeted interventions to address the multi-level effects of gender-based violence on PrEP uptake and adherence among adolescent girls and young women in Kenya
有针对性的干预措施,以解决性别暴力对肯尼亚少女和年轻妇女接受和坚持 PrEP 的多层面影响
- 批准号:
9403567 - 财政年份:2017
- 资助金额:
$ 47.19万 - 项目类别: